<!DOCTYPE html>
<html  >
<head>
  <!-- Site made with Mobirise Website Builder v5.6.5, https://mobirise.com -->
  <meta charset="UTF-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Mobirise v5.6.5, mobirise.com">
  <meta name="twitter:card" content="summary_large_image"/>
  <meta name="twitter:image:src" content="">
  <meta property="og:image" content="">
  <meta name="twitter:title" content="Tacrine">
  <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1">
  <link rel="shortcut icon" href="assets/images/logo-ctbt-bw-negativ-300x97.png" type="image/x-icon">
  <meta name="description" content="">
  
  
  <title>Tacrine</title>
  <link rel="stylesheet" href="assets/web/assets/mobirise-icons2/mobirise2.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap-grid.min.css">
  <link rel="stylesheet" href="assets/bootstrap/css/bootstrap-reboot.min.css">
  <link rel="stylesheet" href="assets/dropdown/css/style.css">
  <link rel="stylesheet" href="assets/socicon/css/styles.css">
  <link rel="stylesheet" href="assets/theme/css/style.css">
  <link rel="preload" href="https://fonts.googleapis.com/css?family=Jost:100,200,300,400,500,600,700,800,900,100i,200i,300i,400i,500i,600i,700i,800i,900i&display=swap" as="style" onload="this.onload=null;this.rel='stylesheet'">
  <noscript><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Jost:100,200,300,400,500,600,700,800,900,100i,200i,300i,400i,500i,600i,700i,800i,900i&display=swap"></noscript>
  <link rel="preload" as="style" href="assets/mobirise/css/mbr-additional.css"><link rel="stylesheet" href="assets/mobirise/css/mbr-additional.css" type="text/css">
  
  
  
  
</head>
<body>
  
  <section data-bs-version="5.1" class="menu menu2 cid-t9u5ogVN8c" once="menu" id="menu2-2w">
    
    <nav class="navbar navbar-dropdown navbar-fixed-top navbar-expand-lg">
        <div class="container-fluid">
            <div class="navbar-brand">
                <span class="navbar-logo">
                    <a href="home.html#top">
                        <img src="assets/images/logo-ctbt-bw-negativ-300x97.png" alt="Mobirise Website Builder" style="height: 3.6rem;">
                    </a>
                </span>
                
            </div>
            <button class="navbar-toggler" type="button" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbarSupportedContent" data-bs-target="#navbarSupportedContent" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation">
                <div class="hamburger">
                    <span></span>
                    <span></span>
                    <span></span>
                    <span></span>
                </div>
            </button>
            <div class="collapse navbar-collapse" id="navbarSupportedContent">
                <ul class="navbar-nav nav-dropdown" data-app-modern-menu="true"><li class="nav-item"><a class="nav-link link text-white text-primary display-4" href="home.html#features1-1i">
                            About us</a></li>
                    <li class="nav-item"><a class="nav-link link text-white text-primary display-4" href="home.html#slider5-2">Technologies</a></li>
                    <li class="nav-item"><a class="nav-link link text-white text-primary display-4" href="home.html#team1-1o">Our Team</a>
                    </li></ul>
                
                <div class="navbar-buttons mbr-section-btn"><a class="btn btn-info display-4" href="home.html#contacts3-8">Contact us</a></div>
            </div>
        </div>
    </nav>
</section>

<section data-bs-version="5.1" class="header14 cid-t9u5of1MOF" id="header14-2q">

    

    

    <div class="container">
        <div class="row justify-content-center align-items-center">
            <div class="col-12 col-md-5 image-wrapper">
                <img src="assets/images/6-1036x1036.png" alt="Mobirise Website Builder">
            </div>
            <div class="col-12 col-md">
                <div class="text-wrapper">
                    <h1 class="mbr-section-title mbr-fonts-style mb-3 display-2"><strong>Dually Acting Tacrine Derivatives for Treatment of Neurodegenerative Disorders</strong></h1>
                    <p class="mbr-text mbr-fonts-style display-7">
                        A dually-acting compounds with neuropsychopharmacological and drug-like properties with potential therapeutic use.</p>
                    <div class="mbr-section-btn mt-3"><a class="btn btn-info-outline display-4" href="assets/files/Tacrine-Derivates.pdf" target="_blank">DOWNLOAD PDF</a></div>
                </div>
            </div>
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="content5 cid-t9u5ofmmm5" id="content5-2r">
    
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-md-12 col-lg-10">
                
                
                <p class="mbr-text mbr-fonts-style display-7">Neurodegenerative disorders (ND) accounts the vast majority of agerelated dementias characterized by progressive cognitive decline of higher mental functions. The research devoted to this field uncovered a pathomechanism of complex multietiology which cannot be addressed by hitting one target.
<br>
<br>Motivated by currently available treatment against ND involving the inhibitors of acetylcholinesterase (AChE) and N-methyl-D-aspartate receptor (NMDAR), administered also in combination, we developed adually-acting compounds based on 1,2,3,4-tetrahydro-9-aminoacridine (tacrine) structure and confirmed their neuropsychopharmacological and drug-like properties for potential therapeutic use.
<br>
<br>Only a few compounds have been established for the treatment of Alzheimer’s disease. For instance, FDA and EMEA have approved three cholinesterase inhibitors, one NMDA-receptor antagonist – memantine and one disease-modifying immunotherapy – aducanumab, for Alzheimer’s disease (AD). Here we offer a combination of both effect in a single molecule. To date there are many other drugs undergoing clinical trials in AD, having various mechanism of action (vaccines against amyloid beta, against Tau protein, antiinflammation drugs) but none of them seems to reach the registration in a short term.
<br>
<br>Novel molecules represent a new way how to cope with the multiple pathogenic factors of ND. Based on our observations, we suppose that these compounds are able to hit additional targets relevant to ND and thus succeed in overcoming the multifactorial pathogenesis. While tacrine (approved for AD treatment in 1993) was withdrawn from the market due to its hepatotoxicity and other side effects in 2013, our compounds were prepared to avoid this hepatotoxic effect as we demonstrated in in vitro studies. Since these compounds have also been found acting as GluN2B selective NMDAR antagonists, they are therefore believed to hold strong therapeutic potential in the treatment of other disorders – e.g. ischemic damage, chronic pain and depression.</p>
            </div>
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="header14 cid-t9u5ofzEz1" id="header14-2s">

    

    

    <div class="container">
        <div class="row justify-content-center align-items-center">
            <div class="col-12 col-md-4 image-wrapper">
                <img src="assets/images/join-2-816x579.png" alt="Mobirise Website Builder">
            </div>
            <div class="col-12 col-md">
                <div class="text-wrapper">
                    
                    <p class="mbr-text mbr-fonts-style display-7">Authors would like to thank the grant of Ministry of Education, Youth and Sports of the Czech Republic (project ERDF no. CZ.02.1.01/0.0/0.0/18_069/0010054).
<br>
<br>1. <a href="https://pubmed.ncbi.nlm.nih.gov/33892271/" class="text-primary" target="_blank">https://pubmed.ncbi.nlm.nih.gov/33892271/
</a><br>
<br>2.  <a href="https://www.sciencedirect.com/science/article/abs/pii/S0006295221000563?dgcid=rss_sd_all" class="text-primary" target="_blank">https://www.sciencedirect.com/science/article/abs/pii/S0006295221000563?dgcid=rss_sd_all</a>
<br>
<br>3. <a href="https://www.tandfonline.com/doi/abs/10.1080/01480545.2019.1566350?journalCode=idct20&" class="text-primary">https://www.tandfonline.com/doi/abs/10.1080/01480545.2019.1566350?journalCode=idct20&amp;</a>
<br>
<br>Technology is owned by University Hospital Hradec Králové together with Institute of Physiology CAS, National Institute of Mental Health and Institute of Experimental Medicine CAS. We are currently seeking for development or commercial partner or licencing. Two Czech patent applications were submitted <strong>PV 2021-24 </strong>and <strong>PV 2021-25</strong>. PCT in preparation (priority date 26. 1. 2021). Technology is going through in vitro validation.<br></p>
                    
                </div>
            </div>
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="team1 cid-t9u5ofPnnd" id="team1-2t">
    

    
    <div class="container">
        <div class="row justify-content-center">
            <div class="col-12">
                <h3 class="mbr-section-title1 mbr-fonts-style align-center mb-5 display-5">
                    <strong>Team of Inventors</strong></h3>
                
            </div>
            <div class="col-sm-6 col-lg-4">
                <div class="card-wrap">
                    <div class="image-wrap">
                        <img src="assets/images/nvrh-bez-nzvu-11-500x500.png" alt="Mobirise Website Builder">
                    </div>
                    <div class="content-wrap">
                        <h5 class="mbr-section-title card-title mbr-fonts-style align-center m-0 display-7"><strong>Assoc. prof. Ondřej Soukup &amp; team</strong></h5>
                        <h6 class="mbr-role mbr-fonts-style align-center mb-3 display-7">University Hospital Hradec Králové</h6>
                        <p class="card-text mbr-fonts-style align-center display-7">Head of Biomedical Research Center UH HK
<br>
<br>Nominee for a Prize of the Mayor of Hradce Králové for research activities &amp; Awarded by the Medal of Hradce Králové for research activities
<br>
<br>Author &amp; coauthor of 150+ scientific publications with IF<br>
<br>Coauthor of 8 book chapters &amp; editor of 1 monograph on Alzheimer's disease &amp; editor of Special Issue with IF 3<br><br>6 patents granted, 1 licensed, 3 utility models granted</p>
                        
                        
                    </div>
                </div>
            </div>

            

            

            
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="features18 cid-t9u5ogmhui" id="features19-2u">

    

    
    <div class="container">
        <div class="row justify-content-center">
            <div class="card col-12 col-lg">
                <div class="card-wrapper">
                    <h6 class="card-title mbr-fonts-style mb-4 display-2"><strong>Contact Us</strong></h6>
                    <p class="mbr-text mbr-fonts-style display-7">For more detailed information, do not hesitate to contact us directly:
<br><strong>Lucie Bartošová, Ph.D.</strong>, <strong>lucie.bartosova@fnhk.cz</strong> or <strong>+420 495 832 925</strong>.
<br>
<br>Stay in touch with us on social media where you can follow recent progress in developing technologies.</p>
                    
                </div>
            </div>
            <div class="col-12 col-lg-4">
                <div class="image-wrapper">
                    <img src="assets/images/nvrh-bez-nzvu-3-500x500.png" alt="Mobirise Website Builder">
                </div>
            </div>
        </div>
    </div>
</section>

<section data-bs-version="5.1" class="footer3 cid-t9u5ogAH1n" once="footers" id="footer3-2v">

    

    

    <div class="container">
        <div class="media-container-row align-center mbr-white">
            <div class="row row-links">
                <ul class="foot-menu">
                    
                    
                    
                    
                    
                <li class="foot-menu-item mbr-fonts-style display-7">
                        <a class="text-white text-primary" href="home.html#features1-1i" target="_blank">About us</a>
                    </li><li class="foot-menu-item mbr-fonts-style display-7"><a href="home.html#slider5-2" class="text-primary">Technologies</a></li><li class="foot-menu-item mbr-fonts-style display-7"><a href="home.html#team1-1o" class="text-primary">Our Team</a></li><li class="foot-menu-item mbr-fonts-style display-7"><a href="home.html#contacts3-8" class="text-primary">Contact Us</a></li></ul>
            </div>
            <div class="row social-row">
                <div class="social-list align-right pb-2">
                    
                    
                    
                    
                    
                    
                <div class="soc-item">
                        <a href="https://twitter.com/rd_uhhk" target="_blank">
                            <span class="mbr-iconfont mbr-iconfont-social socicon-twitter socicon"></span>
                        </a>
                    </div><div class="soc-item">
                        <a href="https://www.facebook.com/fakultninemocnice.hradeckralove" target="_blank">
                            <span class="mbr-iconfont mbr-iconfont-social socicon-facebook socicon"></span>
                        </a>
                    </div><div class="soc-item">
                        <a href="https://www.youtube.com/nemocnicehradec" target="_blank">
                            <span class="mbr-iconfont mbr-iconfont-social socicon-youtube socicon"></span>
                        </a>
                    </div><div class="soc-item">
                        <a href="https://www.linkedin.com/company/fakultn%C3%AD-nemocnice-hradec-kr%C3%A1lov%C3%A9/" target="_blank">
                            <span class="mbr-iconfont mbr-iconfont-social socicon-linkedin socicon"></span>
                        </a>
                    </div></div>
            </div>
            <div class="row row-copirayt">
                <p class="mbr-text mb-0 mbr-fonts-style mbr-white align-center display-7">
                    © All Rights Reserved.
                </p>
            </div>
        </div>
    </div>
</section><section class="display-7" style="padding: 0;align-items: center;justify-content: center;flex-wrap: wrap;    align-content: center;display: flex;position: relative;height: 4rem;"><a href="https://mobiri.se/2733329" style="flex: 1 1;height: 4rem;position: absolute;width: 100%;z-index: 1;"><img alt="" style="height: 4rem;" src="data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACH5BAEAAAAALAAAAAABAAEAAAICRAEAOw=="></a><p style="margin: 0;text-align: center;" class="display-7">Created with Mobirise &#8204;</p><a style="z-index:1" href="https://mobirise.com/website-maker.html">Free Website Maker</a></section><script src="assets/bootstrap/js/bootstrap.bundle.min.js"></script>  <script src="assets/smoothscroll/smooth-scroll.js"></script>  <script src="assets/ytplayer/index.js"></script>  <script src="assets/dropdown/js/navbar-dropdown.js"></script>  <script src="assets/theme/js/script.js"></script>  
  
  
</body>
</html>